Associate Professor, Ophthalmology and Visual Sciences, Washington University School of Medicine
Ophthalmology
Dr. Rajendra S. Apte, MD
|
|
Give Review
Dr. Rajendra S. Apte is an expert in the field of Ophthalmology. He graduated from University of Texas Southwestern Medical School. He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAO)". Rajendra S. Apte is a published doctor and has 72 publications published. The lastest was: 'Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege.' Rajendra S. Apte, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- A systematic review of as needed versus treat and extend ranibizumab or bevacizumab treatment regimens for neovascular age-related Macular degeneration.
- Autophagy supports survival and phototransduction protein levels in rod photoreceptors.
- Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye.
- Subconjunctival bevacizumab for iris neoVascularisation - Authors' reply.
- Expression of nampt in hippocampal and cortical excitatory neurons is critical for cognitive function.
- Regression of iris neovascularisation secondary to Diabetic retinopathy with subconjunctival anti-VEGF therapy.
- Eyeballing cHolesterol efflux and macrophage function in disease pathogenesis.
- Age-Dependent Changes in FasL (CD95L) Modulate Macrophage Function in a Model of Age-Related Macular Degeneration.
- Impaired cholesterol efflux in senescent macrophages promotes age-related Macular degeneration.
- Pattern electroretinography in age-related Macular degeneration.
- N-Acetylcysteine Amide (NACA) Prevents Retinal Degeneration by Up-Regulating Reduced Glutathione Production and Reversing Lipid Peroxidation.
- Effect of preoperative vitreous status on visual outcomes following vitrectomy for epiRetinal membrane repair.
- An observational retrospective subgroup analysis of verteporfin photodynamic therapy-naive and previously treated patients in the focus trial.
- Targeting immune privilege to prevent pathogenic Neovascularization.
- Resveratrol regulates pathologic angiogenesis by a eukaryotic elongation factor-2 kinase-regulated pathway.
- Vitrectomy outcomes in eyes with diabetic Macular edema and vitreoMacular traction.
- Full-thickness Macular hole in a patient with proliferative sickle cell retinopathy.
- Regulation of angiogenesis by macrophages.
- Vascular events in patients with age-related Macular degeneration treated with intraocular bevacizumab.
- SCOREing in Retinal venous occlusive disease.
- Successful treatment of Choroidal blastomycosis with oral administration of voriconazole.
- Association of complement factor H and LOC387715 genotypes with response of exudative age-related Macular degeneration to photodynamic therapy.
- Association of the extent of diabetic Macular edema as assessed by optical coherence tomography with visual acuity and retinal outcome variables.
- Retinal pigment epithelial tears in ranibizumab-treated eyes.
- Interleukin-10 overexpression promotes Fas-ligand-dependent chronic macrophage-mediated demyelinating polyNeuropathy.
- An assay for macrophage-mediated regulation of endothelial cell proliferation.
- Intravitreal bevacizumab for treatment of Choroidal neovascularization secondary to angioid streaks.
- Intravitreal bevacizumab for Choroidal neovascularization in ocular histoplasmosis.
- Angiogenesis in eye disease: immunity gained or immunity lost?
- Pegaptanib sodium for the treatment of age-related Macular degeneration.
- Effect of senescence on macrophage polarization and angiogenesis.
- Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development.
- Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related Macular degeneration: effect of initial visual acuity on treatment response.
- Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice.
- Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related Macular degeneration.
- Spontaneous resolution of an inflammation-associated epiRetinal membrane with previously documented posterior vitreous detachment.
- Clinical phenotypes associated with the complement factor H Y402H variant in age-related Macular degeneration.
- Intravitreal pharmacOtherapy: applications in retinal disease.
- Retrospective analysis of etiopathogenesis of all cases of Endophthalmitis at a large tertiary referral center.
- Inhibiting angiogenesis in retinoblastoma.
- Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic Macular edema.
- Retinal pigment epithelial tear after intravitreal ranibizumab for subfoveal CNV secondary to AMD.
- Short-term intraOcular pressure trends after intravitreal triamcinolone injection.
- Intravitreal bevacizumab for treatment of Choroidal neovascularization in pathologic myopia.
- Macrophages inhibit neovascularization in a murine model of age-related Macular degeneration.
- Retinal pigment epithelial tear following intravitreal pegaptanib sodium.
- A case of intravitreal silicone oil migration to the central nervous system.
- Bilateral Choroiditis from Prototheca wickerhamii algaemia.
- Different effects of angiopoietin-2 in different Vascular beds: new vessels are most sensitive.
- Retinal metastasis presenting as a Retinal hemorrhage in a patient with adenocarcinoma of the cecum.
- Retinal vascular occlusion with overlying vitreous hemorrhage masquerading as a tumor.
- Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.
- Systemic non-Hodgkin B-cell lymphoma encountered as a vanishing Choroidal mass.
- Severe proliferative Retinopathy in a patient with advanced muscular dystrophy.
- Stimulation of Neovascularization by the anti-angiogenic factor PEDF.
- Retrospective case series of juxtafoveal Choroidal neovascularization treated with photodynamic therapy with verteporfin.
- Human intraOcular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.
- Bilateral Macular staphylomas in a patient with cone dystrophy.
- Acute Choroidal infarction following subcutaneous injection of micronized dermal matrix in the forehead region.
- Giant neurosensory detachments associated with disciform lesions in neovascular age related Macular degeneration.
- Foveal congenital hypertrophy of the retinal pigment epithelium in the setting of geographic atrophy from age-related Macular degeneration.
- Idiopathic parafoveal telangiectasis associated with a foveal pseudovitelliform lesion.
- Angiostatin produced by certain primary uveal melanoma cell lines impedes the development of liver metastases.
- Etiology of Blindness in an urban community hospital setting.
- Inhibition of intraOcular tumor growth by topical application of the angiostatic steroid anecortave acetate.
- Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege.
- Local inhibition of natural killer cell activity promotes the progressive growth of intraOcular tumors.
- Effect of hyperthermia on expression of histocompatibility antigens and heat-shock protein molecules on three human Ocular melanoma cell lines.
- Isolation and characterization of a unique natural killer cell inhibitory factor present in the Anterior chamber of the eye.
- Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival.
- SIRT6 Is Required for Normal Retinal Function.
Schools
University Of Mumbai
Procedures Preformed
- Cataract Removal Surgery
- Destruction of Lesion of Retina and Choroid
- Excision or Destruction of Lesion of Sclera
- Ocular Surface Reconstruction
- View All
Conditions Treated
- Age-Related Macular Degeneration
- Anterior Ischemic Optic Neuropathy
- Aphakia and Other Disorders of Lens
- Benign Neoplasm of Choroid
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAO)
Education
-
University of Texas Southwestern Medical School -
L. Tilak Municipal Medical College
Hospital
-
St. Luke's Hospital -
Barnes-Jewish Hospital -
St. Louis Children's Hospital
Drug Facts
| NPI NUMBER | 1528062411 | |
| NPPES Provider LastName | APTE | |
| NPPES Provider FirstName | RAJENDRA | |
| NPPES Provider ZIPCode | 631101032 | |
| NPPES Provider State | MO | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 106.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1528062411 |
| Last Name Of The Provider | APTE |
| First Name Of The Provider | RAJENDRA |
| View All |
Similar Doctors
|
|
Dr. Eric K. Chiu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Josh E. Amato, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sidney T. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles L. Friedman, MD |
|
|
Dr. David E. Vollman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anjali K. Pathak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ross B. Chod, MD |
|
|
Dr. Smith A. Chisholm, MD |
|
|
Dr. Senthil N. Krishnasamy, MD
This Doctor is OpenDoctor Recommended.
|